Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Psychedelics
Algernon Pharmaceuticals Inc. is a Canadian healthcare and clinical-stage pharmaceutical development company. It is also the parent company of a private subsidiary, Algernon NeuroScience Inc., that is advancing a psychedelic program investigating a proprietary form of sub-psychedelic N,N-Dimethyltryptamine (DMT) for stroke and traumatic brain injury. It is focused on developing repurposed... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:AGN)

Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000

GlobeNewswire 11 days ago

Algernon Announces $1M Private Placement

GlobeNewswire May 27, 2025

Algernon closes NoBrainer acquisition

Jonathon Brown May 23, 2025

Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition

GlobeNewswire May 22, 2025

Algernon to Acquire NoBrainer Imaging Centers, Inc. - Plans to Establish Alzheimer's Diagnostic and Treatment Medical Clinics Featuring New PET Scan Technology

GlobeNewswire May 13, 2025

Algernon Announces Warrant Extension

GlobeNewswire May 5, 2025

Algernon Pharmaceuticals Receives Notice of Allowance from European Patent Office for Repirinast for Kidney Disease

GlobeNewswire April 8, 2025

Algernon NeuroScience Engages Netcapital Securities for Planned Regulation A Financing

GlobeNewswire March 6, 2025

Algernon NeuroScience Appoints Globally Recognized DMT Researcher and Clinician Dr. Sándor Nardai as Principal Investigator for Planned Phase 2a DMT Human Stroke Study

GlobeNewswire February 11, 2025
View More News ››

Opinion & Analysis (CSE:AGN)

Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke

Dave Jackson June 16, 2021

Flying Under the Radar with a Possible COVID-19 Treatment

Stockhouse Editorial September 9, 2020

Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19

Streetwise Reports May 29, 2020

Buzz on the Bullboards: Coronavirus, Esports, and Uranium Plays

Omri Wallach April 16, 2020

Buzz on the Bullboards: HOT Coronavirus Healthcare Stocks

Omri Wallach March 19, 2020
View More Opinion ››

Bullboard Posts (CSE:AGN)

Yesterday’s Trading

On the great news of the AD testing opportunity, share price rose 11%. However, subsequent trading brought the price down by 18...
nodaytrader - May 15, 2025

Tenbagger?

Algernon Pharmaceuticals Inc. C.AGN Alternate Symbol(s):  AGNPF You can read through this news and...
Investox - February 6, 2025

Still alive?

An idea for this play, how about repurposing our investment share into crytpo? by the looks of it, if you can find a way of doing that...
Closure70 - December 3, 2024

Today’s Depth Display on CSE

While trade price is hovering around 12 cents, if you remove the Quebec kids (Desjardins and National Bank), from the Depth Display, the...
nodaytrader - July 5, 2024

Yesterday’s Trading

Great was the joy in the sandbox yesterday at the return of Integral after a lengthy absence. Its single trade was an eye-watering $55...
nodaytrader - May 3, 2024

RE:Webinar Recap: $AGN CEO Chris Moreau and Radius Research

We learn in the video of Algernon's potential bring relief from suffering to millions of people around the world. we also learned of...
nodaytrader - May 1, 2024
View more Bullboard ››

Forsys Metals Corp

Forsys Metals Corp

Forsys Metals Corp. is a Canada-based uranium developer. The Company is engaged in the business of acquiring, exploring and ...
View More »